REESE DAVID M has filed 30 insider transactions across 1 company since March 2023.
Most recent transaction: a tax payment of 6022 shares of AMGEN INC ($AMGN) on March 16, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | F | Common Stock | 6022 | $366.21 | 41,787.0000 | 538,800,000 | 12.60% | 0.00% |
| March 3, 2026 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | A | Common Stock | 12063 | $0.00 | 47,650.0000 | 538,800,000 | 33.90% | 0.00% |
| Nov. 11, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | G | Common Stock | 6490 | $0.00 | 35,812.0000 | 538,500,000 | 15.34% | 0.00% |
| Nov. 12, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | G | Common Stock | 309 | $0.00 | 35,503.0000 | 538,500,000 | 0.86% | 0.00% |
| May 6, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | A | Nqso (Right to Buy) | 22944 | $270.44 | 22,944.0000 | 536,900,000 | 9999.99% | 0.00% |
| May 6, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | A | Common Stock | 3549 | $0.00 | 42,116.0000 | 536,900,000 | 9.20% | 0.00% |
| May 2, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | F | Common Stock | 665 | $283.78 | 38,567.0000 | 536,900,000 | 1.70% | 0.00% |
| May 2, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | F | Common Stock | 702 | $283.78 | 39,232.0000 | 536,900,000 | 1.76% | 0.00% |
| April 30, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | F | Common Stock | 768 | $288.56 | 39,934.0000 | 536,900,000 | 1.89% | 0.00% |
| March 17, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | F | Common Stock | 3635 | $313.71 | 40,702.0000 | 536,900,000 | 8.20% | 0.00% |
| March 3, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | A | Common Stock | 7277 | $0.00 | 44,199.0000 | 536,900,000 | 19.71% | 0.00% |
| Feb. 19, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | M | Nqso (Right to Buy) | 8711 | $0.00 | 0.0000 | 536,900,000 | 100.00% | 0.00% |
| Feb. 19, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | M | Common Stock | 8711 | $156.35 | 70,858.0000 | 536,900,000 | 14.02% | 0.00% |
| Feb. 19, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | S | Common Stock | 8711 | $293.22 | 62,147.0000 | 536,900,000 | 12.29% | 0.00% |
| Feb. 21, 2025 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | S | Common Stock | 25225 | $304.44 | 36,922.0000 | 536,900,000 | 40.59% | 0.00% |
| May 7, 2024 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | A | Common Stock | 3196 | $0.00 | 61,889.0000 | 535,400,000 | 5.45% | 0.00% |
| May 7, 2024 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | A | Nqso (Right to Buy) | 20767 | $300.30 | 20,767.0000 | 535,400,000 | 9999.99% | 0.00% |
| May 5, 2024 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | F | Common Stock | 633 | $311.29 | 58,693.0000 | 535,400,000 | 1.07% | 0.00% |
| May 2, 2024 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | F | Common Stock | 650 | $277.37 | 59,326.0000 | 535,400,000 | 1.08% | 0.00% |
| April 30, 2024 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | F | Common Stock | 690 | $276.38 | 59,976.0000 | 535,400,000 | 1.14% | 0.00% |
| March 18, 2024 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | F | Common Stock | 6202 | $268.87 | 60,666.0000 | 535,400,000 | 9.27% | 0.00% |
| March 6, 2024 | AMGEN INC | $AMGN | REESE DAVID M | EVP & Chief Technology Officer | A | Common Stock | 12407 | $0.00 | 66,653.0000 | 535,400,000 | 22.87% | 0.00% |
| Nov. 28, 2023 | AMGEN INC | $AMGN | REESE DAVID M | EVP, Research and Development | G | Common Stock | 165 | $0.00 | 54,164.0000 | 534,000,000 | 0.30% | 0.00% |
| May 5, 2023 | AMGEN INC | $AMGN | REESE DAVID M | EVP, Research and Development | F | Common Stock | 594 | $231.89 | 54,114.0000 | 534,000,000 | 1.09% | 0.00% |
| May 3, 2023 | AMGEN INC | $AMGN | REESE DAVID M | EVP, Research and Development | F | Common Stock | 819 | $235.97 | 54,708.0000 | 534,000,000 | 1.47% | 0.00% |
| May 2, 2023 | AMGEN INC | $AMGN | REESE DAVID M | EVP, Research and Development | A | Common Stock | 3814 | $0.00 | 55,527.0000 | 534,000,000 | 7.38% | 0.00% |
| May 2, 2023 | AMGEN INC | $AMGN | REESE DAVID M | EVP, Research and Development | A | Nqso (Right to Buy) | 32250 | $0.00 | 32,250.0000 | 534,000,000 | 9999.99% | 0.01% |
| April 30, 2023 | AMGEN INC | $AMGN | REESE DAVID M | EVP, Research and Development | F | Common Stock | 666 | $239.74 | 51,713.0000 | 534,000,000 | 1.27% | 0.00% |
| March 17, 2023 | AMGEN INC | $AMGN | REESE DAVID M | EVP, Research and Development | F | Common Stock | 3978 | $234.57 | 52,379.0000 | 534,000,000 | 7.06% | 0.00% |
| March 6, 2023 | AMGEN INC | $AMGN | REESE DAVID M | EVP, Research and Development | A | Common Stock | 7947 | $0.00 | 56,167.0000 | 534,000,000 | 16.48% | 0.00% |